Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 6,193 | 1,429 |
| Cost of Goods | 2,701 | 1,065 |
| Gross Profit | 3,492 | 364 |
| Operating Expenses | 13,856 | 8,663 |
| Operating Income | -9,662 | -8,234 |
| Other Income | 1,454 | 371 |
| Pre-tax Income | -8,209 | -7,863 |
| Net Income Continuous | -8,209 | -7,863 |
| Net Income | $-8,209 | $-7,863 |
| EPS Basic Total Ops | -0.95 | -1.95 |
| EPS Basic Continuous Ops | -0.95 | -1.95 |
| EPS Diluted Total Ops | -0.95 | -1.95 |
| EPS Diluted Continuous Ops | -0.95 | -1.95 |
| EBITDA(a) | $-9,296 | $-7,990 |